GWOXI has been deeply committed to stem cell R&D and clinical translation. The company has already applied for multiple compassionate use projects in partnership with medical institutions. Following the legislative approval of regenerative medicine implementation technology, GWOXI became even more proactive, collaborating with numerous medical centers and clinics. This allows the company to provide patients with emerging medical technology options and better meet their healthcare needs.